Virus reduction method

Patent metadata

Field	Value
Publication number	US-10280195-B2
Application number	US-201415313363-A
Country	US
Kind code	B2
Filing date	May 28, 2014
Priority date	May 28, 2014
Publication date	May 7, 2019
Grant date	May 7, 2019

Abstract

Methods are provided for enhancing reduction of virus and viral DNA levels in protein preparations.

First claim

What is claimed is:

1. A method for reducing virus and viral DNA levels in an acidic preparation comprising a desired protein, the method comprising contacting the acidic preparation with an electropositive surface consisting essentially of one or more primary amines, secondary amines, or both, wherein an operating pH during the contacting step is from about 2.0 to about 4.0.

2. The method of claim 1 , wherein the operating pH during the contacting step is in a range selected from the group consisting of (a) from about 2.25 to about 3.75, (b) from about 2.5 to about 3.5, (c) from about 2.75 to about 3.25, (d) from about 3.5 to about 3.75, and (e) from about 3.25 to about 3.5.

3. The method of claim 1 , wherein a salt concentration during the contacting step is in a range selected from the group consisting of (a) from about 0.0 to about 0.5 M, (b) from about 0.05 to about 0.3 M, and (c) from about 0.1 to about 0.2M.

4. The method of claim 1 , wherein the duration of the contacting step is in a range selected from the group consisting of (a) from about 15 to about 120 minutes, (b) from about 30 to about 60 minutes, (c) a non-zero amount less than about 30 minutes, (d) a non-zero amount less than about 15 minutes, (e) a non-zero amount less than about 10 minutes, (f) a non-zero amount less than about 5 minutes, (g) a non-zero amount less than about 2 minutes, (h) a non-zero amount less than about 1 minute, and (i) a time required to pass the preparation through a device housing the electropositive surface.

5. The method of claim 1 , wherein the one or more primary or secondary amines are selected from the group consisting of ethylenediamine, tris(2-aminoethyl)amine, diethylaminetriamine, triethylenetetraamine, tetraethylenepentamine, and a polyallylamine.

6. The method of claim 1 , wherein the electropositive surface is selected from the group consisting of a particle, a membrane, a monolith, and a hydrogel-coated skeletal framework.

7. The method of claim 1 , wherein the contacting step is performed by an operation selected from the group consisting of (a) dispersing primary or secondary amine-bearing particles in the preparation, (b) passing the preparation through a device wherein the preparation is in fluid contact with the electropositive surface, and (c) recirculating the preparation through a device wherein the preparation is in fluid contact with the electropositive surface.

8. A method for reducing an amount of a virus in a preparation comprising a virus and a desired protein, the method comprising:
(i) contacting the preparation with an electropositive surface consisting essentially of one or more primary amines or secondary amines, wherein the preparation has a pH less than 4.0; and
(ii) separating the desired protein from the electropositive surface and the virus, wherein the electropositive surface comprises the virus.

9. The method of claim 8 , wherein the preparation has a pH in a range from about 2.0 to about 3.75.

10. The method of claim 8 , wherein a salt concentration of the preparation during the contacting step is from about 0.0 to about 0.5 M.

11. The method of claim 8 , wherein the contacting step comprises a duration of about 15 to about 120 minutes.

12. The method of claim 8 , wherein the one or more primary or secondary amines are selected from the group consisting of ethylenediamine, tris(2-aminoethyl)amine, diethylaminetriamine, triethylenetetraamine, tetraethylenepentamine, and polyallylamine.

13. The method of claim 8 , wherein the electropositive surface consists essentially of one or more primary amines.

14. The method of claim 13 , wherein the one or more primary amines consists of ethylenediamine.

15. The method of claim 8 , wherein the electropositive surface comprises particles, a membrane, a monolith, or a hydrogel-coated skeletal framework.

16. The method of claim 8 , wherein the contacting step is performed by an operation selected from the group consisting of (a) dispersing primary or secondary amine-bearing particles in the preparation, (b) passing the preparation through a device in fluid contact with the electropositive surface, and (c) recirculating the preparation through a device while providing contact of the preparation with the electropositive surface.

17. The method of claim 8 , wherein the preparation comprises viral DNA and after the separating of (ii) the electropositive surface retains substantially all of the viral DNA.

18. The method of claim 8 , wherein the preparation has a pH in a range from about 2.0 to about 3.75, and the electropositive surface comprises ethylenediamine.

19. The method of claim 8 , wherein after (ii) the electropositive surface comprises substantially all of the virus.

Assignees

• Agency Science Tech & Res

Inventors

• Gagnon Peter Stanley

Classifications

• B01J20/3248

  the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such · CPC title

• B01D15/168

  pH gradient or chromatofocusing, i.e. separation according to the isoelectric point pI · CPC title

• B01D15/363

  Anion-exchange · CPC title

• B01J41/20

  Anion exchangers for chromatographic processes · CPC title

• B01J20/28016

  Particle form · CPC title